Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-243
Mol Pharmacol. September 1, 2006; 70 (3): 801-5.

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.

Mihalak KB , Carroll FI , Luetje CW .


Abstract


PubMed ID: 16766716
Article link: Mol Pharmacol.
Grant support: DA08102 NIDA NIH HHS , DA12001 NIDA NIH HHS , MH66038 NIMH NIH HHS, T32-HL07188 NHLBI NIH HHS


Resources URL:


My Xenbase: [ Log-in / Register ]
version: [4.1.1]

Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556